KRW 50 billion worth of the Nexium market… having conflicts with improved new generics

The Nexium (Esomeprazole) Market reaching collective KRW 35 billion for the third quarter of the year is like the calm before the storm.

Despite the aggressive sales marketing of improved new drugs, Nexium, the original product that has drawn continuous rising curve on sales due to the increase of reflux esophagitis patients, got back in the generic market with lower price on last September.